J. Mark Jackson, MD, FAAD
Board-Certified Dermatologist
5.0/5
Google Reviews
Dr. Jackson is a Clinical Professor of Medicine (Dermatology) at the University of Louisville. Dr. Jackson is active in the dermatology residency program and spends time teaching dermatology residents and medical students. He is also involved in clinical investigational research, as well as in clinical practice. Dr. Jackson has authored many chapters and articles in peer reviewed publications and has lectured throughout the country on topics involving acne, lupus, psoriasis, eczema, systemic therapies for dermatologic diseases and advanced dermatologic disorders. He sees patients primarily at the Louisville office, but also staffs the dermatology clinic at the University of Louisville. Dr. Jackson also serves as an investigator and consultant for pharmaceutical companies in research and drug development.
Undergraduate Degree
Baylor University - Waco, TX
Medical School
Texas A&M College of Medicine - Bryan, TX
Internal Medicine Residency
Texas A&M College of Medicine - Bryan, TX
Dermatology Residency
University of Louisville - Louisville, KY
- American Board of Dermatology
- American Academy of Dermatology
- American Medical Association
- American Board of Dermatology
- Dermatology Foundation Leaders Society
- Medical Dermatology Society
- American Acne and Rosacea Society
- Kentucky Dermatological Association
- Kentucky Medical Association
- Greater Louisville Medical Society
- North American Rheumatologic Dermatology Society
- Jefferson County Medical Society
- Voted Best Dermatologist Louisville Magazine
- Upjohn Achievement Award for Virtues Most Admired in a Physician
- Department of Internal Medicine Award for Excellence
- Golden Apple Award for Outstanding Resident Teacher
- Roche Overall Award for Clinical Research, Resident/Intern Division
- American Academy of Family Physicians Award for Research
- Jackson JM, Fowler JF, Callen JP, Lorenz DJ; Mycophenolate mofetil for the treatment An open-label study. J Drugs Dermatol 2010;9:356-62.
- Fowler J, Jackson, J, Jarrat M, et al: Once Daily brimonidine tartrate gel 0.5% is a moderate to severe facial erythema of rosacea: results of two randomized, multi-centre, vehicle controlled studies. Br J Dermatol 2012:166:633-41.
- Fowler JF, Jackson JM, Steinhoff M, et al: Topical brimonidine tartrate gel is safe and treatment of moderate to severe facial erythema of rosacea. JDrugsDermatol, June 2013.
Schedule an appointment with Dr. Jackson
Forefront Dermatology
501 S 2nd St
Louisville, KY 40202
Medical dermatology
Cosmetic dermatology
Skin cancer treatment
Loading map...